Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.05B P/E - EPS this Y - Ern Qtrly Grth -
Income -2.33B Forward P/E -8.64 EPS next Y - 50D Avg Chg -17.00%
Sales 88.03M PEG - EPS past 5Y - 200D Avg Chg -71.00%
Dividend N/A Price/Book 0.22 EPS next 5Y 26.00% 52W High Chg -85.00%
Recommedations 1.60 Quick Ratio 7.31 Shares Outstanding 82.65M 52W Low Chg 25.00%
Insider Own 0.71% ROA -20.92% Shares Float 37.92M Beta 0.82
Inst Own 57.46% ROE -45.65% Shares Shorted/Prior 3.73M/4.23M Price 12.70
Gross Margin 47.25% Profit Margin - Avg. Volume 1,300,563 Target Price 89.52
Oper. Margin -2,274.00% Earnings Date Mar 29 Volume 877,651 Change 5.92%
I-MAB News
05/12/22 We're Hopeful That I-Mab (NASDAQ:IMAB) Will Use Its Cash Wisely
05/05/22 I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act
04/28/22 I-Mab Announces Appointments of Richard Yeh as Chief Operating Officer and John Hayslip as Chief Medical Officer
04/20/22 Chinese Biotech I-Mab Weighing Options Including Sale
03/31/22 I-Mab Announces Voluntary Lock-ups by Key Shareholders and Senior Management for Long-Term Commitment
03/29/22 I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2021
03/25/22 Hong Kong SPAC Rush Attracts Olympic Champions to Sofa Moguls
03/18/22 I-Mab to Report Full Year 2021 Financial Results and Provide Corporate Update on March 29, 2022
03/15/22 Further weakness as I-Mab (NASDAQ:IMAB) drops 40% this week, taking one-year losses to 76%
03/15/22 I-Mab Provides Updates Regarding Holding Foreign Companies Accountable Act
03/09/22 I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
03/03/22 I-Mab Receives FDA Orphan Drug Designation for its Novel Claudin 18.2 x 4-1BB Bispecific Antibody TJ-CD4B for the Treatment of Gastric Cancer
03/01/22 Billionaire Ray Dalio’s Top 10 Small-Cap Stock Picks
02/26/22 Campbell Wilson’s Old Well Partners Is Buying These 10 Stocks
02/08/22 Strategic Vision Investment Ltd Buys Amazon. ...
01/28/22 I-Mab Announces Partnership Agreement to Localize Manufacturing and Accelerate Commercialization of Innovative Biologics Drugs
01/27/22 Dorsey Wright & Associates Buys Coterra Energy Inc, Fortinet Inc, Icon PLC, Sells RH, ...
01/18/22 I-Mab Announces First Patient Dosed in China Phase 2 Combination Trial of Lemzoparlimab with Toripalimab in Patients with Advanced Solid Tumors
01/14/22 I-Mab Announces Execution of Senior Management Team Share Purchase Plan

I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase III clinical trials to treat multiple myeloma and autoimmune diseases; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinical trials to treat pediatric growth hormone deficiency; Lemzoparlimab, a CD47 monoclonal antibody that has completed Phase 1a clinical trials with RBC-sparing differentiation; and Olamkicept, an IL-6 blocker that has completed Phase 2 clinical trials for the treatment of ulcerative colitis and autoimmune. Its product candidates also includes Enoblituzumab, a humanized B7-H3 antibody that is in Phase 2 to treat head and neck cancer, and other oncology diseases; Efineptakin, a long-acting recombinant human IL-7, which is in Phase 2 clinical trials to treat glioblastoma multiforme patients with lymphopenia; TJ210, a monoclonal antibody against human C5aR1 that is in Phase 1 for the treatment of cancers and autoimmune; Plonmarlimab, a GM-CSF monoclonal antibody that is in Phase 2 clinical trials for rheumatoid arthritis and CAR-T-related therapies; Uliledlimab, a CD73 antibody, which is in Phase I/2 clinical trials for treating solid tumors and oncology; TJ-L14B, a PD-L1-based tumor-dependent T-cell engager for solid cancers; and TJ-CD4B, a tumor-dependent T cell engager for gastric and other cancers. Its product candidates in pre-clinical development stage comprises TJX7, a novel CXCL13 antibody for autoimmune diseases; and TJ-C4GM antibodies for treating oncology diseases. I-Mab has strategic collaboration agreement with AbbVie Ireland Unlimited Company; Sinopharm Group Co. Ltd.; PT Kalbe Genexine Biologics; and Roche Diagnostics. The company was founded in 2014 and is headquartered in Shanghai, the People's Republic of China.

IMAB Chatroom

User Image Option_Swings Posted - 1 day ago

$IMAB Even more institutional investors are loading today!

User Image The_Perfect_Wave Posted - 3 days ago

$IMAB Friday's market winners! IMAB | 10.8% [Search Criteria] Symbol closed 10% or more in gain.

User Image shortvolumes Posted - 3 days ago

Short sale volume (not short interest) for $IMAB on 2022-05-13 is 47%. http://shortvolumes.com/?t=IMAB via @shortvolumes

User Image Option_Swings Posted - 3 days ago

$IMAB Picked up $30,000 worth 🍾 Also now have $6,500 of $YI as well! Imab institutional investor recent buys are to promising..

User Image MrBigRevenue Posted - 4 days ago

$IMAB always a good sign when ray dalios bridgewater buys

User Image MrBigRevenue Posted - 4 days ago

$IMAB vanguard and bridgewater loaded Today

User Image MrBigRevenue Posted - 4 days ago

$IMAB several institutions loaded this yesterday including Blackrock

User Image shortablestocks Posted - 5 days ago

$IMAB is short sale restricted for 2022-05-12. https://www.shortablestocks.com/?IMAB

User Image JohnTill Posted - 6 days ago

$ZLAB Well that was quick. Out of ZLAB at 30.50 and rolled the quick 15% all into $IMAB.

User Image Option_Swings Posted - 6 days ago

$YI $IMAB looking to start a position here soon but can’t tell with how overall it’s still trending down. Any China/US news soon? I got around 40k to put into these two once the time is right. I’m liking these two over doyu and huya as chinas gaming regulations are absurd

User Image dividendinvestorbyeagle Posted - 6 days ago

$IMAB close decreased > 10% (I-Mab) https://www.dividendinvestor.com/dividend-news/?symbol=imab

User Image algoslinger Posted - 1 week ago

$IMAB is up 11.235% from market open on 701,145 volume. Now trading at $11.98. #IMAB #tenpercentscan

User Image MrBigRevenue Posted - 1 week ago

$IMAB keep loading this

User Image baerenmarkt Posted - 1 week ago

$IMAB Holding til it pops.

User Image MrShort Posted - 1 week ago

$IMAB Estimated S.I as on 5/9/22 18.44 Percent My Portfolio is up 28% last month even in these Market Conditions. I developed a spread sheet for top 50 companies ( highly Shorted) to calculate the Short loss based on the average price & average days the stock is loaned. This is will be helpful to make a call when the price will be reversed. Fundamentals, upcoming catalyst also play to its part in this reverse action. Please visit my home page for more information. *The content provided in post is for information purpose only – please do you due diligence before investing.

User Image BidaskBot Posted - 1 week ago

IMab $IMAB BidaskScore is #Reiterated to StronglySold https://bidaskclub.com/news/company/2022-05-03/IMAB

User Image JohnTill Posted - 1 week ago

$IMAB So the question is how far does this fall before a buyout for 70% premium? $860M market cap with $670M is cash, $3 billion is future deals, 10 drugs ready to go and another 10 in the works. No way someone should get to buy this for under $20. They locked up the shares since they knew the buyout was coming. I just hope they do not let it sink much farther before this gets done. Was a large buyer today near close but barely got my average below $12. Getting ugly out there.

User Image tickeron Posted - 1 week ago

Does this make you nervous? $IMAB's Aroon indicator drops into Downtrend on May 6, 2022. View odds for this and other indicators: https://srnk.us/go/3648712

User Image JohnTill Posted - 1 week ago

$YI This is the reason I was sitting in over 65% cash the last few weeks - bought some more of my favorites today and low ball bids also in - $VIOT $ZEPP $IMAB . Love a good sale.

User Image shortvolumes Posted - 1 week ago

Short sale volume (not short interest) for $IMAB on 2022-05-06 is 67%. http://shortvolumes.com/?t=IMAB via @shortvolumes

User Image Islanders71 Posted - 1 week ago

$AABB $IMAB $WWR $TBLT $STSS Watch List $AABB or don't? lol LG! https://finance.yahoo.com/quote/AABB?p=AABB&.tsrc=fin-srch

User Image MrShort Posted - 1 week ago

$IMAB Estimated S.I as on 5/6/22 18.44 Percent My Portfolio is up 28% last month even in these Market Conditions. I developed a spread sheet for top 50 companies ( highly Shorted) to calculate the Short loss based on the average price & average days the stock is loaned. This is will be helpful to make a call when the price will be reversed. Fundamentals, upcoming catalyst also play to its part in this reverse action. Please visit my home page for more information. *The content provided in post is for information purpose only – please do you due diligence before investing.

User Image JohnTill Posted - 1 week ago

$IMAB Always amazes me how good these ratio work out. The IMAB/ZLAB ratio bounced exactly where expected. I should have shorted ZLAB when I mentioned thas as it hit that high but instead I ended up buying $ZLAB at close today as these ratio closes back to support. Got stopped out of IMAB at $13 but also back in today at $11.90. So now own both and will buy on Monday weakness again. One of these days these will start the leg back up and these stops for small profits are getting boring. The blame for the 20% drop seems to be going to Guggenheim for cutting their price target on ZLAB to $85 (only 300% from here). I blame China fears, which will pass.

User Image InsiderForms Posted - 1 week ago

IvyRock Asset Management (HK) Ltd,has filed Form 13F for Q1 2022.Opened NEW positions in $CRM $HTHT $IMAB $OLPX $TSM

User Image briefingcom Posted - 1 week ago

$IMAB provided updates on its status under the Holding Foreign Companies Accountable Act https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20220505080913IMAB&utm_campaign=inplay&utm_medium=social&utm_source=twitter&utm_content=view_page

User Image Quantisnow Posted - 1 week ago

$IMAB 📰 I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act https://quantisnow.com/i/2834330?utm_source=stocktwits 45 seconds delayed.

User Image Stock_Titan Posted - 1 week ago

$IMAB I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act https://www.stocktitan.net/news/IMAB/i-mab-provides-updates-on-status-under-holding-foreign-companies-tl3nltmysr1y.html

User Image Newsfilter Posted - 1 week ago

$IMAB I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act https://newsfilter.io/a/d5c265379065adb4f9a187457abfe4a7

User Image ChartMill Posted - 2 weeks ago

$TDOC, $IMAB and $SHLS are the top gainers for the day. https://www.chartmill.com/stock/stock-screener?v=3&f=sl_pt_4_X,p_pg10,v1_50b500,exch_us&s=pt&utm_source=stocktwits&utm_medium=screener&utm_content=Stock_Screener:_top_gainers&utm_campaign=social_tracking

User Image Islanders71 Posted - 2 weeks ago

$AABB $TBLT $MMAT $IMAB $WWR $AABB CEO purchased 2.4 million dollars of $AABB stock https://aabbgoldtoken.com/latest-news/nft-marketplace-what-is-it-and-what-are-the-latest-trends/2022/05/02/

Analyst Ratings
HC Wainwright & Co. Buy Mar 30, 22
Needham Buy Nov 1, 21
HC Wainwright & Co. Buy Sep 1, 21
Cantor Fitzgerald Overweight Jun 10, 21
Daiwa Capital Buy Jun 2, 21
Needham Buy Mar 15, 21
H.C. Wainwright Buy Mar 3, 21
Piper Sandler Overweight Feb 25, 21
HC Wainwright & Co. Buy Dec 7, 20